Upregulation of ErBb2 may either produce metastasis-related characteristics like angiogenesis or invasion, or it may promote curative resistance, ultimately deteriorating cancer cell metastasis and attempting distressing responses to cancer-curative MMP-9 and MMP-2 protein activities [80]. This evidence concerns the gene ERBB2 and cancer.